Glass; David J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Glass; David J..The latest application filed is for "methods for preventing and treating heart disease".

Company Profile

1.14.18

Glass; David J. - West Des Moines IA
GLASS; David J. - Cambridge MA
Glass; David J. - Cortlandt Manor NY US
Glass; David J. - White Plains NY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Crop orientation system and method Grant 11,337,356 - Helmich , et al. May 24, 2	2022-05-24
Methods For Preventing And Treating Heart Disease App 20210309749 - ROSENZWEIG; Anthony ; et al.	2021-10-07
Crop Orientation System And Method App 20210282309 - Helmich; Sam R. ; et al.	2021-09-16
Work Machine Zone Generation And Control System With Geospatial Constraints App 20210176916 - SIDON; Jeffrey S. ; et al.	2021-06-17
Methods for treating and/or reducing the likelihood of heart failure by administering anti-activin receptor type II (anti-ActRII) antibody Grant 10,982,000 - Rosenzweig , et al. April 20, 2	2021-04-20
Methods For Preventing And Treating Heart Disease App 20200031940 - ROSENZWEIG; Anthony ; et al.	2020-01-30
IGF-1 fusion polypeptides and therapeutic uses thereof Grant 8,445,434 - Glass , et al. May 21, 2	2013-05-21
Igf-1 Fusion Polypeptides And Therapeutic Uses Thereof App 20120195896 - GLASS; David J. ; et al.	2012-08-02
IGF-1 fusion polypeptides and therapeutic uses thereof Grant 8,158,581 - Glass , et al. April 17, 2	2012-04-17
Igf-1 Fusion Polypeptides And Therapeutic Uses Thereof App 20110020342 - GLASS; DAVID J. ; et al.	2011-01-27
Method of increasing muscle mass with IGF-1 fusion polypeptides Grant 7,837,999 - Glass , et al. November 23, 2	2010-11-23
IGF-1 and IGF-2 chimeric polypeptides and therapeutic uses thereof Grant 7,781,404 - Glass August 24, 2	2010-08-24
Method of treating a muscle-related condition with modified IGF1 polypeptides Grant 7,632,503 - Stitt , et al. December 15, 2	2009-12-15
Igf-1 And Igf-2 Chimeric Polypeptides And Therapeutic Uses Thereof App 20090175864 - Glass; David J.	2009-07-09
IGF-1 and IGF-2 chimeric polypeptides and therapeutic uses thereof Grant 7,521,211 - Glass April 21, 2	2009-04-21
IGF-1 Fusion Polypeptides and Therapeutic Uses Thereof App 20090069235 - GLASS; David J. ; et al.	2009-03-12
Method of treating a muscle-related condition with modified IGF1 polypeptides App 20080199479 - Stitt; Trevor ; et al.	2008-08-21
IGF-I fusion polypeptides and therapeutic uses thereof Grant 7,396,918 - Glass , et al. July 8, 2	2008-07-08
Modified IGF1 polypeptides with increased stability and potency Grant 7,355,018 - Glass April 8, 2	2008-04-08
Ion channel receptor and uses thereof Grant 7,122,648 - Glass October 17, 2	2006-10-17
IGF-I and IGF-2 chimeric polypeptides and therapeutic uses thereof App 20060223753 - Glass; David J.	2006-10-05
Myostatin inhibiting fusion polypeptides and therapeutic methods thereof App 20060216279 - Glass; David J. ; et al.	2006-09-28
IGF-I fusion polypeptides and therapeutic uses thereof App 20060166328 - Glass; David J. ; et al.	2006-07-27
Secreted protein therapeutics and uses thereof App 20050287151 - Glass, David J.	2005-12-29
Tyrosine kinase receptors and ligands Grant 6,852,838 - Valenzuela , et al. February 8, 2	2005-02-08
HIV-specific fusion proteins and therapeutic and diagnostic methods for use App 20040214285 - Glass, David J. ; et al.	2004-10-28
Ion channel receptor and uses thereof App 20040018547 - Glass, David J.	2004-01-29
Novel nucleic acid and polypeptide molecules App 20030129686 - Glass, David J. ; et al.	2003-07-10
Novel tyrosine kinase receptors and ligands App 20020164702 - Valenzuela, David M. ; et al.	2002-11-07
Methods of identifying agents affecting atrophy and hypertrophy App 20020123456 - Glass, David J.	2002-09-05
Tyrosine kinase receptors and ligands Grant 5,814,478 - Valenzuela , et al. September 29, 1	1998-09-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.